Halozyme Therapeutics (HALO)

Earnings in 2024 (TTM): ₹46.93 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are ₹1.01 Billion. , an increase over its 2023 earnings that were of ₹30.41 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2024

Annual earnings

Year	Earnings	Change
2024	₹48.65 B	59.94%
2023	₹30.41 B	39.94%
2022	₹21.73 B	0.16%
2021	₹21.70 B	92.2%
2020	₹11.29 B	-278.96%
2019	-₹6.31 Billion	-9.45%
2018	-₹6.97 Billion	-229.51%
2017	₹5.38 B	-160.48%
2016	-₹8.9 Billion	216.03%
2015	-₹2.82 Billion	-52.86%
2014	-₹5.98 Billion	-18.09%
2013	-₹7.29 Billion	55.88%
2012	-₹4.68 Billion	169.94%
2011	-₹1.74 Billion	-63.44%
2010	-₹4.74 Billion	-7.19%
2009	-₹5.11 Billion	15.91%
2008	-₹4.41 Billion	83.89%
2007	-₹2.4 Billion	78.1%
2006	-₹1.35 Billion	16%
2005	-₹1.16 Billion	45.24%
2004	-₹0.8 Billion	682.42%
2003	-₹0.11 Billion	1659.12%
2002	-₹5.8 Million

Earnings for similar companies or competitors

Company	Earnings	Earnings differencediff.	Country
MannKind Corp MNKD	₹2.18 B	-95.51%	🇺🇸 USA
Eli Lilly LLY	₹1.107 T	2,176.01%	🇺🇸 USA
Baxter BAX	₹14.49 B	-70.20%	🇺🇸 USA
Pfizer PFE	₹606.31 B	1,146.20%	🇺🇸 USA
Sanofi SNY	₹693.55 B	1,325.52%	🇫🇷 France
Johnson & Johnson JNJ	₹1.523 T	3,030.68%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2024 (TTM): ₹46.93 Billion